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Abstract
The secreted molecule fibroblast growth factor 9 (FGF9) plays a critical role in testis determination in the mouse. In
embryonic gonadal somatic cells it is required for maintenance of SOX9 expression, a key determinant of Sertoli cell fate.
Conditional gene targeting studies have identified FGFR2 as the main gonadal receptor for FGF9 during sex determination.
However, such studies can be complicated by inefficient and variable deletion of floxed alleles, depending on the choice of
Cre deleter strain. Here, we report a novel, constitutive allele of Fgfr2, hobbyhorse (hob), which was identified in an ENU-
based forward genetic screen for novel testis-determining loci. Fgr2hob is caused by a C to T mutation in the invariant exon
7, resulting in a polypeptide with a mis-sense mutation at position 263 (Pro263Ser) in the third extracellular
immunoglobulin-like domain of FGFR2. Mutant homozygous embryos show severe limb and lung defects and, when on
the sensitised C57BL/6J (B6) genetic background, undergo complete XY gonadal sex reversal associated with failure to
maintain expression of Sox9. Genetic crosses employing a null mutant of Fgfr2 suggest that Fgr2hob is a hypomorphic allele,
affecting both the FGFR2b and FGFR2c splice isoforms of the receptor. We exploited the consistent phenotype of this
constitutive mutant by analysing MAPK signalling at the sex-determining stage of gonad development, but no significant
abnormalities in mutant embryos were detected.
Citation: Siggers P, Carre´ G-A, Bogani D, Warr N, Wells S, et al. (2014) A Novel Mouse Fgfr2 Mutant, Hobbyhorse (hob), Exhibits Complete XY Gonadal Sex
Reversal. PLOS ONE 9(6): e100447. doi:10.1371/journal.pone.0100447
Editor: Andrew Wolfe, John Hopkins University School of Medicine, United States of America
Received March 22, 2014; Accepted May 23, 2014; Published June 23, 2014
Copyright:  2014 Siggers et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Data Availability: The authors confirm that all data underlying the findings are fully available without restriction. All relevant data are included within the paper.
Funding: This work was funded by the UK Medical Research Council through Core funding to AG at its Mammalian Genetics Unit, Harwell (MC_A390_5RX50). The
funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* Email: a.greenfield@har.mrc.ac.uk
Introduction
Fibroblast growth factors (FGF) function in numerous processes
throughout embryonic development, such as the induction and
patterning of germ cell layers, body axis formation and organo-
genesis [1]. Out of 22 human and mouse FGFs, 18 bind to a
distinct set of cell-surface FGF receptors (FGFRs) to initiate intra-
cellular signalling that results in cellular responses, including cell
proliferation and differentiation [2]. Our understanding of the
physiological roles of FGF ligands and their receptors has been
helped enormously by the study of mouse knockouts [1]. Ranging
from early embryonic lethality to adult metabolic abnormalities,
these mutant phenotypes reveal the breadth of impact of FGF
signalling.
Testis determination in the embryo normally requires the Y-
linked gene Sry to initiate the commitment of somatic cells in the
developing bipotential gonad to the Sertoli cell fate [3]. SRY
effects this commitment through its positive effects on the
expression of Sox9, a gene that is itself necessary and sufficient
for testis development [4]. The analysis of mice lacking FGF9 first
revealed a role for this signalling pathway in testis determination.
Fgf9-deficient animals die around birth due to severe lung
hypoplasia and, on a mixed genetic background, XY embryos
exhibit a range of gonadal abnormalities ranging from testicular
hypoplasia to complete sex reversal [5]. On the C57BL/6J (B6)
background, which is sensitised to disruptions to testis determina-
tion, XY Fgf9-deficient embryos consistently exhibit gonadal sex
reversal, indicating that some of the earliest processes in testis
determination are disrupted by the absence of FGF9 [6].
Subsequent studies revealed an important role for FGF9 in
maintaining high levels of Sox9 expression in the developing XY
gonad, mediated at least partly by its inhibitory effects on ovary-
determining genes such as Wnt4 [7,8]. It has also been proposed
that the rapid diffusion of secreted FGF9 along the long, thin
gonad at around 11.5 dpc prevents any appreciable delay in the
gonadal poles receiving the masculinising signal begun by
expression of SRY at the centre of the gonad [9]. Any such delay
may result in ovotestis or ovary development in an XY embryo
due to the restricted time window that is thought to define the
competence of cells to respond to SRY and its downstream
effectors [10].
FGF9 acts as a paracrine FGF, mediating its effects locally by
binding to and activating one of four tyrosine kinase FGFRs, using
heparin sulphate proteoglycan (HSPG) cofactor-association as a
means of regulating ligand distribution and receptor binding [11].
Loss-of-function genetic studies have identified FGFR2 as the
likely receptor for embryonic gonadal FGF9. Embryos lacking
FGFR2 die mid-gestation, at around 10.5 dpc, precluding a study
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of the effects of this loss on testis determination. Conditional gene
targeting revealed partial XY gonadal sex reversal when Fgfr2
deletion was restricted temporally, from around 10.5 dpc onwards,
or spatially, to gonadal somatic cells [12]. Similar XY gonadal
defects, including ovotestis and ovary development, were observed
after mosaic deletion of Fgfr2 in the embryo using Ck19Cre [13].
Limb and lung defects were also common in these embryos.
Expression analysis in isolated pre-Sertoli cells indicates that one of
the two isoforms of Fgfr2, Fgfr2c, is found in this lineage [12]. In
contrast, both the Fgfr2b and Fgfr2c isoforms are detectable in other
gonadal cells. Thus, these data suggest that FGFR2 is required for
Sertoli cell differentiation and testis development through its
activation by FGF9 ligand.
Despite the wealth of data concerning FGF signalling and its
role in testis determination, the mechanism by which the gonadal
FGF signal is transduced intracellularly remains unclear. In other
contexts, a number of pathways are implicated, including PI3K-
AKT and RAS-MAPK signalling [2]. Here, we report the
identification of a novel, constitutive mutation of Fgfr2, hobby-
horse (hob). Fgfr2hob homozygotes exhibit severe lung hypoplasia
and absence of limbs, in addition to complete XY gonadal sex
reversal on the sensitised B6 background. We exploit the
phenotypic robustness of this model of FGF-dependent sex
reversal to address the role of MAPK signalling in transducing
the FGF signal during testis determination.
Materials and Methods
Mouse strains used and genotyping
All animal experimentation was approved by the Animal
Welfare and Ethical Review Body (AWERB) at MRC Harwell
and mice used in this study were bred with licensed approval from
the UK Home Office (PPL 30/2877). Mice were housed in
individually ventilated cages (IVCs) in a specific pathogen-free
(SPF) environment. Further details of micro- and macro-environ-
mental conditions are available on request. Adult mice were
humanely sacrificed by dislocation of the neck, confirmed by
palpation, and embryos were decapitated in ice-cold, phosphate-
buffered saline solution. Mice harbouring Fgfr2tm1.1Dor were
generated by breeding a floxed allele of Fgfr2 (Fgfr2tm1Dor/J, The
Jackson Laboratory) with the ubiquitous Cre deleter FVB/N-
Tg(ACTB-Cre)2Mrt/J (The Jackson Laboratory) after at least three
generations of backcrossing of each strain to C57BL/6J. Cre-mediated
deletion of the floxed locus removes exons 7–10, generating a non-
functional Fgfr2 allele. Presence of the Fgfr2hob allele was detected with a
LightScanner assay using the primers Fgfr2ex7F 59-CCTTT-
CTCCATCAGAACGGTCA-39 and Fgfr2ex7R 59-CTGTAAAC-
CTTGCAGACAAACTC-39 with mutant probe: Fgfr2ex7 PrR 59-
GAGGCATTTGCAGACAGTCCAGCTT-39.
Details of ENU mutagenesis, the three-generation breeding
scheme and genome-wide mapping of developmental mutants
identified have been described elsewhere [14–16]. Adult mice and
embryos were sexed by a PCR assay that simultaneously amplifies
the Ube1y1 and Ube1x genes, using the following primer pair: 59-
TGGATGGTGTGGCCAATG-39 and 59-CACCTGCACGTT-
GCCCTT-39 [17].
Generation of embryos and expression analyses
Noon on the day of the copulatory plug was counted as 0.5 dpc.
Embryos were staged accurately based on the number of tail
somites (ts) or limb and gonad morphology. In the case of hob/hob
embryos, somites were counted from the presumptive hindlimb
bud, which appears as a thickening of the body wall in the area of
the hindlimb field and is present up to approximately 12.5 dpc.
Wholemount in situ hybridization (WMISH) analysis of embryonic
tissues was performed as previously described [18]. Probes for Sox9
[19], Sry [20], Insl3 [17], Wnt4 and Stra8 [14,21] have been
previously described. WMISH was performed on at least three
independent gonad samples from each embryonic class.
Immunohistochemistry
Antibodies to the following proteins were utilised in this study:
SOX9 (Millipore, #AB5535); AMH (Santa Cruz, #sc28912);
FOXL2 (a kind gift from Dagmar Wilhelm and Peter Koopman
[22]); SRY (a kind gift from Makoto Tachibana, Kyoto University
[23]); Cell Signaling antibodies - p38 MAPK (CST9212),
phospho-p38 MAPK (CST9215), ERK (CST9102) and phos-
pho-ERK (CST4377); 12G10 alpha-tubulin (Developmental
Studies Hybridoma Bank, University of Iowa). Immunostaining
was performed on sectioned, paraffin wax-embedded tissue from
two independent gonad samples using the above primary
antibodies (1:100) and Alexa Fluor 594 (AMH, SOX9) or 488
(FOXL2, SRY) conjugated secondary antibodies (1:200). Images
were captured using a Zeiss 710 multiphoton microscope.
Protein detection by Simple Western analysis
Pooled sub-dissected gonads (n = 8) were lysed using 50 ml RIPA
buffer (150 mM NaCl, 1% NP40, 0.5% sodium deoxycholate,
0.1% SDS, 50 mM Tris, pH 7.5) supplemented with Aqueous and
DMSO inhibitor cocktails (Protein Simple), and cell debris
removed by centrifugation. Lysates (7.5 ml) were mixed with
2.5 ml of Simple Western sample dilution buffer (Protein Simple)
containing reducing agent and fluorescent standards, and dena-
tured at 95uC for 5 min. Lysates (10 ml), primary antibodies,
horseradish peroxidase–conjugated secondary antibodies, separa-
tion matrix, stacking matrix and chemiluminescent substrate were
dispensed into designated wells in a 384-well assay plate. Simple
Western assay buffers, capillaries and the prepared assay plate
were placed in Peggy instrument (Protein Simple), which carries
out all assay steps automatically for up to 8 cycles. Briefly, proteins
were separated through a size-resolving matrix in capillaries,
immobilized to the inner capillary wall, incubated with primary
and secondary antibodies before detection using chemilumines-
cence. Signal and quantitation of immunodetected proteins were
generated automatically at the end of the run. Statistical analysis
was performed on data from three biological replicates (24 gonad
samples in total).
Results
Identification of the hobbyhorse (hob) mutation: an allele
of Fgfr2 that disrupts limb, lung and gonad development
We have previously described a forward genetic screen
employing N-ethyl-N-nitrosourea (ENU) mutagenesis aimed at
identifying novel loci required for mouse development. This screen
identified recessive mutations in genes functioning in neural tube
closure and patterning [15], left-right patterning [16] and sex
determination [14]. We identified a second pedigree in this screen
(RECB/135) containing embryos with gonadal abnormalities at
14.5 dpc. Affected XY gonads exhibited a range of morphological
abnormalities, ranging from disruption to cord formation through
to complete absence of testis cords (Fig 1A). This variability is
likely to be due to the mixed genetic background on which the
screen was performed. Affected embryos also lacked limbs and had
severely hypoplastic lungs (Fig 1B,C); due to their external
appearance the mutants were called hobbyhorse (hob).
Using seven affected embryos and a genome-wide panel of
polymorphic markers, we mapped the mutation responsible for
Fgfr2 Hobbyhorse Mutation and Testis Determination
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this phenotype to distal mouse chromosome 7, between the
markers rs6317573 and rs32097269 (data not shown). The
phenotypic combination of lung, limb and gonadal abnormalities
was strongly reminiscent of defects in FGF/FGFR signalling
previously reported [5,12,13], and inspection of the critical linkage
region identified the Fgfr2 gene. We amplified and sequenced Fgfr2
exons in genomic DNA from affected and unaffected embryos and
identified a homozygous C to T mutation in exon 7 of all, and
only, affected individuals (Fig 1D). This mutation results in a
predicted proline to serine mis-sense amino acid substitution at
position 263 (P263S) of the FGFR2 polypeptide chain. The
affected proline residue is highly conserved in vertebrates (Fig1E)
and resides in the third extracellular immunoglobulin-like domain
(IgIII, D3) of FGFR2 (Fig 1F). Moreover, exon 7 is an invariant
exon in Fgfr2 mRNA isoforms and so this mutation is predicted to
affect both the Fgfr2b and Fgfr2c isoforms. The extracellular region
of FGFRs encompassing the second and third Ig-like domains (D2,
D3) and the intervening linker region is necessary and sufficient for
FGF ligand binding [24]. Specificity of ligand binding by FGFR2
is determined by alternate splicing in the D3 domain.
Complete gonadal sex reversal in XY Fgfr2hob/hob
embryos on C57BL/6J
We crossed the Fgfr2hob mutation to C57BL/6J (B6) for at least
three generations to remove contaminating mutations and to
examine gonad development in homozygotes on this sensitised
genetic background. Adult heterozygotes were fertile and exhib-
ited no overt abnormalities, suggesting that Fgfr2hob is a genuine
recessive mutation. B6 XY embryos homozygous for the Fgfr2hob
mutation exhibited complete gonadal sex reversal, as evidenced by
the ovarian morphology and the absence of the Sertoli cell marker,
Sox9, at 14.5 dpc and the high levels of the ovarian somatic marker
Wnt4 (Fig 2A); in addition, expression of Stra8 was also observed in
XY mutant gonads, indicating entry of germ cells into meiosis and
thus germ cell sex-reversal (Fig 2A). Homozygous embryos still
lacked limbs; a presumptive hindlimb bud, which appears as a
Figure 1. The hobbyhorse (hob) mutation disrupts XY sex determination and is caused by an ENU-induced point mutation of Fgfr2.
A) A wild-type XY gonad (left) showing characteristic testicular morphology at 14.5 dpc, in contrast to two XY hobbyhorse mutants identified in a
forward genetic screen, which have disrupted testis cords (centre) or lack cords entirely (right). All gonads shown are after wholemount in situ
hybridisation (WMISH) with a Sox9 probe. B) A hobbyhorse mutant (right) lacks limbs. A wild-type embryo is also shown (left). C) Absence of lung
development in a hobbyhorse embryo (right), in contrast to normal lungs at the same stage (left). D) Sequence trace showing homozygosity for a C
to T mutation (asterisk) in exon 7 of Fgfr2 of a hobbyhorse embryo. Upper trace is wild-type, lower trace is hobbyhorse. E) The proline residue that is
mutated in the hob allele is highly conserved in vertebrates. Mm, Mus musculus; Hs, Homo sapiens; Gg, Gallus gallus; Xl, Xenopus leavis; Dr, Danio rerio.
F) Diagrammatic representation of FGFR2 and its domain structure in the FGFR2b and FGFR2c isoforms. The hob mutation (asterisk) resides in the
third extracellular immunoglobulin-like domain, encoded by the invariant exon 7.
doi:10.1371/journal.pone.0100447.g001
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thickening of the body wall in the area of the hindlimb field, was
present up to approximately 12.5 dpc, as previously described in
some embryos homozygous for a null allele of Fgfr2 (data not
shown) [25]. Homozygous embryos also had hypoplastic lungs
(data not shown) but were otherwise viable until late in gestation.
In order to confirm that homozygosity for Fgfr2hob alone accounted
for the mutant phenotype, we performed a genetic complemen-
tation test with an Fgfr2 null allele (Fgfr2tm1.1Dor). We first confirmed
that embryos homozygous for Fgfr2tm1.1Dor were dying from around
10.5–11.0 dpc and lacked limb buds (Fig 2B). We then generated
embryos carrying a single copy of both Fgfr2hob and Fgfr2tm1.1Dor. In
contrast to Fgfr2tm1.1Dor homozygotes, doubly heterozygous embry-
os were alive at 14.5 dpc, though they were slightly smaller than
wild-type littermates and had no limbs and exhibited lung
hypoplasia (Fig 2C and data not shown). XY gonads from doubly
heterozygous embryos had an ovarian morphology and exhibited
negligible Sox9 expression at 13.5 dpc and Stra8-positive germ cells
at 14.5 dpc (Fig 2D). From this complementation assay we
conclude that homozygosity for the Fgfr2hob mutation accounts for
limb, lung and gonadal abnormalities identified in the RECB/135
pedigree. Moreover, based on the fact that Fgfr2hob/m1.1Dor double
heterozygotes survive for longer than Fgfr2tm1.1Dor homozygotes, we
infer that Fgfr2hob is a hypomorphic allele. Genetic interaction tests
involving Fgfr2hob and a null allele of Map3k4 [14] did not, in
contrast, generate embryonic gonads with overt abnormalities (Fig
S1).
Cellular and molecular phenotyping of XY Fgfr2hob/hob
gonads
We then performed a more detailed analysis of gonad
development in XY Fgfr2hob/hob homozygous embryos on B6
between 11.5 dpc and 14.5 dpc. Immunostaining revealed anti-
Mu¨llerian hormone (AMH), a marker of Sertoli cells, in the testis
cords of wild-type gonads at 12.5 dpc, but none was detected in
mutant gonadal tissue (Fig 3A–C). In contrast, the ovarian somatic
marker FOXL2 was detected in mutant gonads at 12.5 dpc, but
not in wild-type XY controls (Fig 3D–F). Sex reversal extended to
the steroidogenic lineage, with no Insl3 transcript detected in XY
mutants at 14.5 dpc (Fig 3G–I). However, Oct4 expression was
detectable in both XY and XX Fgfr2hob/hob homozygotes at 11.5
dpc (Fig 3J–M) and 13.5 dpc (Fig 3N–Q), suggesting no overt
disruption to germ cell development at this stage.
Previously, loss of FGF9 has been associated with disruption to
Sox9 expression, but Sry expression has been reported to be
unaffected [7]. We first examined Sry in XY Fgfr2hob/hob embryos
using WMISH and anti-SRY immunostaining of gonads at 11.5
dpc (from 16–18 tail somites (ts)). Neither of these methods
revealed any disruption to Sry expression (Fig 4A–C). This is in
agreement with a previous report on one Fgfr2 CKO [13]. In
contrast, Sox9 expression, as assayed by WMISH and immuno-
staining, whilst initially up-regulated at 18 ts (Fig 4D–F), was
observed at greatly reduced levels at 23 ts (around 11.75 dpc) in
mutant gonads (Fig 4G–I) and at 12.5–13.0 dpc (Fig 4J–L),
consistent with data reported concerning Sox9 expression in Fgf9-
deficient gonads [7]. Thus, data concerning the molecular basis of
sex reversal in XY Fgfr2hob homozygotes indicate normal up-
regulation of Sox9, but a failure to maintain significant levels
beyond 11.5 dpc.
Figure 2. Characterisation of XY Fgfr2hob/hob embryonic gonad
development on the C57BL/6J (B6) background and comple-
mentation test with the Fgfr2tm1.1Dor null allele. A) WMISH analysis
of gonads at 14.5 dpc from XY wild-type, XX wild-type and XY Fgfr2hob/hob
embryos using a marker of the Sertoli cell lineage (Sox9), ovarian somatic
cells (Wnt4) and meiotic germ cells (Stra8). B) Embryos homozygous for
the Fgfr2tm1.1Dor allele (Dor/Dor) are much smaller than wild-type controls
(+/+) at 11.5 dpc and also lack limbs. C) Embryos at 14.5 dpc doubly
heterozygous for the Fgfr2hob and Fgfr2tm1.1Dor alleles (Dor/hob) lack limbs
and are noticeably smaller than wild-type controls (+/+). D) Upper panel:
Sox9 WMISH of 13.5 dpc embryonic gonads from control and XY
Fgfr2tm1.1Dor/hob doubly heterozygous embryos; lower panel: Stra8WMISH
of 14.5 gonads from embryos of same genotypes as upper panel. The
developmental stage of the doubly heterozygous gonad in the lower
panel appears significantly retarded when compared to the XX control.
doi:10.1371/journal.pone.0100447.g002
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MAPK signalling in Fgfr2hob/hob homozygous gonads at
11.5 dpc
The FGF signal is transduced intra-cellularly by means of a
number of pathways, including PI3K-AKT and RAS-MAPK
signalling [2]. Based on the profile of Sox9 expression in mutant
gonads, which indicates defective expression from around 11.75
dpc, we performed a quantitative analysis of MAPK signalling in
Fgfr2hob/hob homozygous gonads at around 11.5 dpc (16–18 ts) in
order to identify potential abnormalities in signalling that might
result in subsequent defects in Sox9 expression. Gonadal tissue
from XY and XYhob/hob embryos was dissected away from the
mesonephros and protein lysates were examined using a size-
based, capillary electrophoresis method for immunodetection of
the phosphorylated and non-phosphorylated forms of p38 MAPK
and ERK 1/2. Both of these MAPKs are activated in develop-
mental contexts by the FGF signal [26,27]. At 16–18 ts no
significant differences were observed between control and mutant
gonadal tissue samples in the levels of phospho-p38 MAPK
(Fig 5A, B). Unfortunately, we were unable to detect p-ERK at this
stage in gonadal tissue, despite the fact that ERK itself was
detectable and control samples from cultured cells indicated that
the anti-p-ERK antibody was working reliably (data not shown).
Discussion
Here we report the identification, in a mouse forward genetic
screen, of a novel sex-reversing mutant allele of Fgfr2. Previous
studies of Fgfr2 function in testis determination have relied on
conditional gene targeting, with the attendant variability in
efficiency and site of gene ablation resulting in some phenotypic
variation. Homozygous deletion of floxed Fgfr2 alleles using Sf1-
Cre, which is expressed primarily in somatic cells within the
gonad, resulted in partial XY sex reversal, with ovotestis formation
commonly observed at 15.5 dpc [12]. Deletion of Fgfr2 with
Ck19:Cre, a line that deletes in epiblast-derived cells in a mosaic
fashion, also resulted in variable and partial XY gonadal sex
reversal [13]. Complete sex reversal was observed after Fgfr2
deletion at 10.5 dpc with a heat-shock inducible Cre line, Hs-Cre,
but there were variable numbers of SOX9-positive cells observed
in mutant gonads [12]. Incomplete deletion of floxed alleles may
contribute to phenotypic variability, as might residual genetic
background variation. The constitutive Fgfr2hob allele affords a
detailed study of the role of FGFR2 in mouse sex determination on
a stable genetic and phenotypic background. The value of forward
genetics in the identification of developmental loci, including the
provision of new and useful alleles of genes of known function, is
underlined by this study.
Our data suggest that Fgfr2hob is a hypomorphic mutant allele,
perhaps disrupting interaction of FGFR2 with its ligand, given the
position of the altered amino acid in the extracellular immuno-
globulin-like domain. This prediction requires testing in a future
study. The extended viability of Fgfr2hob/hob embryos, in compar-
ison to Fgfr2tm1.1Dor/tm1.1Dor homozygotes that completely lack
FGFR2 function, is also suggestive of an overcoming of an early
placental defect in Fgfr2hob/hob embryos. It is this placental defect
that is thought to account for the death of Fgfr2tm1.1Dor/tm1.1Dor
homozygotes at around 11.5 dpc. The amelioration of this
placental defect is in contrast to the persistent absence of limbs
and severe lung hypoplasia that is a common phenotypic feature of
homozygotes for both alleles. This discrepancy might be explained
by a lower threshold of FGFR2 function in the developing
placenta, greater functional redundancy with respect to FGF
receptor signalling in this tissue or distinct ligand sensitivities to the
hob mutation. With respect to the relative importance of the Fgfr2b
Figure 3. Complete XY gonadal sex reversal in Fgfr2hob/hob
embryos on B6. A–C) Immunostaining with anti-AMH antibody of
gonadal sections from XY wild-type (A), XX wild-type (B) and XY
Fgfr2hob/hob (C) embryos at 12.5 dpc. D–F) anti-FOXL2 immunostaining
of samples equivalent to those in A–C. G–I) WMISH for Insl3 (a marker of
Leydig cells) of gonads with same genotypes as A–C. J–M) Oct4 WMISH
of 11.5 dpc (17 ts) gonads from control XY (J), XX (K), XY Fgfr2hob/hob and
XX Fgfr2hob/hob gonads. N–Q) Oct4 WMISH of 13.5 dpc gonads from
embryos of the same genotype as J-M.
doi:10.1371/journal.pone.0100447.g003
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and Fgfr2c isoforms in testis determination, our data do not allow
us to discriminate because we predict that the hob allele disrupts
both isoforms of the receptor. It will be important to carefully
analyse gonad development in mice specifically lacking either the
Fgfr2b or Fgfr2c isoform on the B6 genetic background in order to
determine their individual contributions to testis determination.
Gonadal sex reversal in XY Fgfr2hob/hob embryos is associated
with a failure to maintain high levels of the key testis
determinant, SOX9, after 11.5 dpc. In contrast, the pro-
ovarian gene Wnt4 is elevated, indicating sex reversal of the
supporting cell lineage. These data are consistent with
observations of failure to maintain Sox9 expression in Fgf9-
deficient XY gonads [7]. In contrast, Sry expression appears to
remain unaffected by disruption of FGF9/FGFR2 signalling.
Recent studies involving phenotypic analysis of XY embryos
lacking Fgf9 and Wnt4 suggest that the primary role of FGF9
may be to inhibit the activity of WNT/b-catenin signalling [8].
The mechanistic basis of this at the molecular level remains
unclear, but Fgfr2hob/hob embryos may offer a useful tool for
investigating such antagonistic interactions of the testis- and
ovary-determining gene regulatory networks (Carre & Green-
field). However, an inhibitory role for FGF9/FGFR2 signalling
may suggest that the search for targets of FGF-dependent
signalling in the gonad should be extended to proteins
associated with ovary development and canonical WNT
signalling more generally.
We have exploited the relative stability of the XY Fgfr2hob/hob
embryonic phenotype to perform careful quantitation of
MAPK signalling during the testis-determining stages of
gonadogenesis and report no significant deficits at early stages
(16–18 ts). We have previously reported a role for p38 MAPK
signalling in regulation of Sry expression and testis determina-
tion [28]. The unaltered levels of phospho-p38 MAPK at 16-
18 ts in Fgfr2hob/hob embryonic gonads are therefore consistent
with the observation of normal Sry expression in this sex-
reversing mutant. Technical improvements may be required to
detect any p-ERK present and thereby determine whether a
role exists for this MAPK in regulating expression of Sox9
during testis determination, as reported in other contexts [29].
It will also be important to analyse the phosphorylation status
of any transcription factor implicated in regulation of Sox9 or
Wnt4 expression in Fgfr2hob/hob embryos, or cellular models
derived from these, in future studies.
Figure 4. Normal Sry expression, but disrupted Sox9 expres-
sion, in XY Fgfr2hob/hob embryonic gonads. A) Sry WMISH at 11.5
dpc (16 ts) showing expression in XY wild-type (left) and XY Fgfr2hob/hob
(right) gonads. B, C) anti-SRY immunostaining at 18 ts in wild-type (B)
and XY Fgfr2hob/hob (C) gonads. D) Sox9 WMISH at 18 ts with tissue
samples as described in (A). E, F) anti-SOX9 immunostaining at 18 ts in
XY wild-type (E) and XY Fgfr2hob/hob (F) gonads. G) Sox9 WMISH at 23 ts
in XY wild-type (left) and XY Fgfr2hob/hob (right) gonads. H, I) anti-SOX9
immunostaining at 23 ts in XY wild-type (H) and XY Fgfr2hob/hob (I) gonads.
J) Sox9 WMISH at 12.5 dpc in XY wild-type (left) and XY Fgfr2hob/hob (right)
gonads. K, L) anti-SOX9 immunostaining at 13.0 dpc in wild-type (K) and XY
Fgfr2hob/hob (L) gonads.
doi:10.1371/journal.pone.0100447.g004
Figure 5. Quantitation of phospho-p38 MAPK (p-p38) levels in gonadal samples at 11.5 dpc (16–18 ts) in XYwild-type and Fgfr2hob/hob
gonads. A) Lane view images showing Simple Western detection of p-p38, p38, and a-tubulin. B) Graph showing the ratio of p-p38 to tubulin in the
two gonadal genotypes. The ratio of p-p38 to p38 was similarly unaltered. Errors were calculated using standard error mean.
doi:10.1371/journal.pone.0100447.g005
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Supporting Information
Figure S1 Absence of genetic interaction between
Fgfr2hob (hob) and Map3k4tm1Flv (M4). Stra8 WMISH of
control gonads and gonads from doubly heterozygous embryos (+/
hob, +/M4). Expression is only detected in control XX gonads.
(TIF)
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